AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA

Clinical trials for AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.

Never miss a new study

Get alerted when new AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA trials appear

Sign up with your email to follow new studies for AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug tested for patients whose immune systems attack their own blood

Disease control Recruiting now

This early-stage trial is testing a new injectable drug called OM336 in adults whose immune systems mistakenly destroy their own red blood cells or platelets. The main goal is to check if the drug is safe and well-tolerated in people who have not fully responded to at least one p…

Matched conditions: AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA

Phase: PHASE1 • Sponsor: Ouro Medicines • Aim: Disease control

Last updated Mar 23, 2026 15:29 UTC

AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA

Get alerted when new AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA trials appear

New drug tested for patients whose immune systems attack their own blood